Evidence map›Paper›PMID 40141988›Full record

ReviewMolecules (Basel, Switzerland)2025

Excipients for Cerium Dioxide Nanoparticle Stabilization in the Perspective of Biomedical Applications.

Svetlana A Titova, Maria P Kruglova, Victor A Stupin, Natalia E Manturova, Raghu Ram Achar, Gouri Deshpande, Vladimir A Parfenov, Ekaterina V Silina

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Biological Applications of Functionalized Cerium Oxide Nanoparticles.International journal of medical sciences · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Svetlana A TitovaI.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.ORCID 0009-0009-8457-0222
Maria P KruglovaI.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.ORCID 0000-0001-6939-160X
Victor A StupinPirogov Russian National Research Medical University, Moscow 117997, Russia.ORCID 0000-0002-9522-8061
Natalia E ManturovaPirogov Russian National Research Medical University, Moscow 117997, Russia.
Raghu Ram AcharJSS Academy of Higher Education & Research, Mysuru 570015, Karnataka, India.ORCID 0000-0001-8196-3703
Gouri DeshpandeRegional Institute of Education (RIE NCERT), Mysuru 570006, Karnataka, India.ORCID 0000-0003-4228-5254
Vladimir A ParfenovI.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.
Ekaterina V SilinaI.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.ORCID 0000-0002-0246-5149

Funding

Russian Science Foundation 23-65-10040
6 · The paper itself

Abstract

Rare earth metal nanoparticles, some of which are already widely used in medicine, are of growing interest in the modern scientific community. One of the promising rare earth metals for biomedical applications is cerium, specifically its oxide form, which is characterized by a higher level of stability and safety. According to a number of studies, cerium dioxide has a wide range of biological effects (regenerative, antimicrobial, antioxidant, antitumor), which justifies the interest of its potential application in medicine. However, these effects and their intensity vary significantly across a number of studies. Since cerium dioxide was used in these studies, it can be assumed that not only is the chemical formula important, but also the physicochemical parameters of the nanoparticles obtained, and consequently the methods of their synthesis and modification with the use of excipients. In this review, we considered the possibilities of using a number of excipients (polyacrylate, polyvinylpyrrolidone, dextran, hyaluronic acid, chitosan, polycarboxylic acids, lecithin, phosphatidylcholine) in the context of preserving the biological effects of cerium dioxide and its physicochemical properties, as well as the degree of study of these combinations from the point of view of the prospect of creating drugs based on it for biomedical applications.

Indexed as

CeriumExcipientsMetal NanoparticlesNanoparticlesHumansceric oxideCeriumExcipientsbiopolymerscarboxylic acidscerium oxidechitosancollagendextranexcipientslanthanidesliposomesnanoceriumnanoparticlesrare earth metals

Identifiers

PMID40141988
PMCPMC11944302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.